1. Home
  2. ALDX vs EBTC Comparison

ALDX vs EBTC Comparison

Compare ALDX & EBTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • EBTC
  • Stock Information
  • Founded
  • ALDX 2004
  • EBTC 1989
  • Country
  • ALDX United States
  • EBTC United States
  • Employees
  • ALDX N/A
  • EBTC N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • EBTC Major Banks
  • Sector
  • ALDX Health Care
  • EBTC Finance
  • Exchange
  • ALDX Nasdaq
  • EBTC Nasdaq
  • Market Cap
  • ALDX 398.3M
  • EBTC 446.9M
  • IPO Year
  • ALDX 2014
  • EBTC 2005
  • Fundamental
  • Price
  • ALDX $2.12
  • EBTC $34.14
  • Analyst Decision
  • ALDX Strong Buy
  • EBTC
  • Analyst Count
  • ALDX 3
  • EBTC 0
  • Target Price
  • ALDX $9.67
  • EBTC N/A
  • AVG Volume (30 Days)
  • ALDX 3.3M
  • EBTC 38.1K
  • Earning Date
  • ALDX 05-01-2025
  • EBTC 04-22-2025
  • Dividend Yield
  • ALDX N/A
  • EBTC 2.96%
  • EPS Growth
  • ALDX N/A
  • EBTC 0.32
  • EPS
  • ALDX N/A
  • EBTC 3.12
  • Revenue
  • ALDX N/A
  • EBTC $168,758,000.00
  • Revenue This Year
  • ALDX N/A
  • EBTC N/A
  • Revenue Next Year
  • ALDX N/A
  • EBTC N/A
  • P/E Ratio
  • ALDX N/A
  • EBTC $10.82
  • Revenue Growth
  • ALDX N/A
  • EBTC 4.53
  • 52 Week Low
  • ALDX $1.14
  • EBTC $22.60
  • 52 Week High
  • ALDX $7.20
  • EBTC $44.41
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 26.33
  • EBTC 29.87
  • Support Level
  • ALDX $1.79
  • EBTC $32.86
  • Resistance Level
  • ALDX $2.32
  • EBTC $37.19
  • Average True Range (ATR)
  • ALDX 0.49
  • EBTC 1.51
  • MACD
  • ALDX -0.32
  • EBTC -0.41
  • Stochastic Oscillator
  • ALDX 17.53
  • EBTC 10.31

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About EBTC Enterprise Bancorp Inc

Enterprise Bancorp Inc is a holding company engaged in the business of gathering deposits from the general public and investing in loans and investment securities. Through the Bank and its subsidiaries, the company offers a range of commercial, residential, and consumer loan products, deposit products, and cash management services, as well as wealth management and wealth services.

Share on Social Networks: